Uso da celulose liofilizada em lesões de nervos periféricos com perda de substância

Bacterial Cellulose-A Remarkable Polymer as a Source for Biomaterials Tailoring

Nowadays, the development of new eco-friendly and biocompatible materials using ‘green’ technologies represents a significant challenge for the biomedical and pharmaceutical fields to reduce the destructive actions of scientific research on the human body and the environment. Thus, bacterial cellulose (BC) has a central place among these novel tailored biomaterials. BC is a non-pathogenic bacteria-produced polysaccharide with a 3D nanofibrous structure, chemically identical to plant cellulose, but exhibiting greater purity and crystallinity. Bacterial cellulose possesses excellent physicochemical and mechanical properties, adequate capacity to absorb a large quantity of water, non-toxicity, chemical inertness, biocompatibility, biodegradability, proper capacity to form films and to stabilize emulsions, high porosity, and a large surface area. Due to its suitable characteristics, this ecological material can combine with multiple polymers and diverse bioactive agents to develop new materials and composites. Bacterial cellulose alone, and with its mixtures, exhibits numerous applications, including in the food and electronic industries and in the biotechnological and biomedical areas (such as in wound dressing, tissue engineering, dental implants, drug delivery systems, and cell culture). This review presents an overview of the main properties and uses of bacterial cellulose and the latest promising future applications, such as in biological diagnosis, biosensors, personalized regenerative medicine, and nerve and ocular tissue engineering.

Nanocomposite and bio-nanocomposite polymeric materials/membranes development in energy and medical sector: A review

Nanocomposite and bio-nanocomposite polymer materials/membranes have fascinated prominent attention in the energy as well as the medical sector. Their composites make them appropriate choices for various applications in the medical, energy and industrial sectors. Composite materials are subject of interest in the polymer industry. Different kinds of fillers, such as cellulose-based fillers, carbon black, clay nanomaterials, glass fibers, ceramic nanomaterial, carbon quantum dots, talc and many others have been incorporated into polymers to improve the quality of the final product. These results are dependent on a variety of factors; however, nanoparticle dispersion and distribution are major obstacles to fully using nanocomposites/bio-nanocomposites materials/membranes in various applications. This review examines the various nanocomposite and bio-nanocomposite materials applications in the energy and medical sector. The review also covers the variety of ways for increasing nanocomposite and bio-nanocomposite materials features, each with its own set of applications. Recent researches on composite materials have shown that polymeric nanocomposites and bio-nanocomposites are promising materials that have been intensively explored for many applications that include electronics, environmental remediation, energy, sensing (biosensor) and energy storage devices among other applications. In this review, we studied various nanocomposite and bio-nanocomposite materials, their controlling parameters to develop the product and examine their features and applications in the fields of energy and the medical sector.

Bacterial cellulose modified using recombinant proteins to improve neuronal and mesenchymal cell adhesion

A wide variety of biomaterials and bioactive molecules have been applied as scaffolds in neuronal tissue engineering. However, creating devices that enhance the regeneration of nervous system injuries is still a challenge, due the difficulty in providing an appropriate environment for cell growth and differentiation and active stimulation of nerve regeneration. In recent years, bacterial cellulose (BC) has emerged as a promising biomaterial for biomedical applications because of its properties such as high crystallinity, an ultrafine fiber network, high tensile strength, and biocompatibility. The small signaling peptides found in the proteins of extracellular matrix are described in the literature as promoters of adhesion and proliferation for several cell lineages on different surfaces. In this work, the peptide IKVAV was fused to a carbohydrate-binding module (CBM3) and used to modify BC surfaces, with the goal of promoting neuronal and mesenchymal stem cell (MSC) adhesion. The recombinant proteins IKVAV-CBM3 and (19)IKVAV-CBM3 were successfully expressed in E. coli, purified through affinity chromatography, and stably adsorbed to the BC membranes. The effect of these recombinant proteins, as well as RGD-CBM3, on cell adhesion was evaluated by MTS colorimetric assay. The results showed that the (19)IKVAV-CBM3 was able to significantly improve the adhesion of both neuronal and mesenchymal cells and had no effect on the other cell lineages tested. The MSC neurotrophin expression in cells grown on BC membranes modified with the recombinant proteins was also analyzed.

Análises histológica e morfométrica do uso de membrana biossintética de celulose em trocleoplastia experimental de cães

O objetivo deste trabalho foi avaliar a aplicação de membrana biossintética de celulose, de fabricação nacional, após a realização da trocleoplastia experimental, com intuito de verificar se o uso desta poderia favorecer a migração de células com potencial condrogênico. Foram utilizados 12 cães adultos, de ambos os sexos, sadios e sem alterações no aparelho locomotor. Os animais foram submetidos ao procedimento de trocleoplastia em ambos os membros pélvicos, após tranquilização e anestesia epidural. Na trocleoplastia do membro esquerdo foi aplicada membrana biossintética à base de celulose (grupo tratado, GT), fixada à cartilagem por meio de pontos simples separados com Poliglactina 910 6-0; no membro direito, foi realizada apenas a trocleoplastia, constituindo o grupo controle (GC). Os animais foram subdivididos em quatro subgrupos de acordo com o período final de avaliação aos 15, 30, 60 e 90 dias do pós-operatório. Após artrotomia exploratória nos momentos pré-estabelecidos, foi realizada biópsia da região da trocleoplastia para avaliação histológica e morfométrica do tecido de reparação. Aos 30 e 60 dias do pós-operatório, notou-se a presença de maior número de células semelhantes a condrócitos nas lesões tratadas com celulose em relação ao membro contra-lateral, apesar do aspecto imaturo. Aos 90 dias, o tecido de reparação era do tipo fibrocartilaginoso maduro, não havendo diferenças entre os dois grupos. No GC houve aumento progressivo do número de células até o período final de avaliação. Por outro lado no grupo tratado verificou-se que, em relação ao período inicial (15 dias), houve aumento do número de células até os 60 dias, com subseqüente retorno aos valores iniciais aos 90 dias. Dos 15 aos 60 dias o número de células foi maior no GT em relação ao GC. Inicialmente, o tecido de reparação neoformado foi mais espesso no grupo tratado. Dessa forma, conclui-se que a membrana de celulose acelerou o processo de reparação tecidual inicial da região da trocleoplastia, apresentando boa integração do tecido neoformado com a cartilagem adjacente.

Biomechanical evaluation of microbial cellulose (Zoogloea sp.) and expanded polytetrafluoroethylene membranes as implants in repair of produced abdominal wall defects in rats

PURPOSE: To evaluate the Load of Rupture of implants of membranes of microbial cellulose (Zoogloea sp.) and extended polytetrafuoroethylene in sharp defects of abdominal wall of rats. METHODS: Sixty Wistar male rats, with a mean weight of 437,7g ± 40,9, anesthetized by a mixture of ketamine (5mg/100g) and xylazine (2mg/100g), were submitted to a rectangular (2x3cm) excision of the abdominal wall, including fascia, muscle and peritoneum, and treated with membranes of microbial cellulose (MC) (MC Group- 30 animals) or extended polytetrafluoroethylene (ePTFE) (ePTFE Group- 30 animals). Each group was subdivided in 14th POD, 28th POD and 60th POD Subgroups. Under anesthesia, animals were submitted to euthanasia at 14th POD, 28th POD and 60th POD for evaluation of Load of Rupture. RESULTS: Load of Rupture levels were significantly elevated (p<0, 05) among 14th, 28th and 60th postoperative days from each Group. When compared between groups, values of Load of Rupture were significantly larger (p<0, 05) in ePTFE Group than in MC Group. CONCLUSION: Resistance to strength at implant/host interface was more pronounced in PTFEe Group than in MC Group.

Biosynthetic cellulose induces the formation of a neoduramater following pre-natal correction of meningomyelocele in fetal sheep

PURPOSE: The aim of this study was to compare the effectiveness of two dura-mater substitutes, namely human acellular dermal matrix (HADM) and biosynthetic cellulose (BC), in repairing, in utero, surgically-induced meningomyelocele (MMC) in fetal sheep. METHODS: A neural tube defect was created at 74-77 days gestation in 36 fetal sheep. They were divided into 3 groups, the control group that did not receive pre-natal corrective surgery, and the other two groups that received corrective surgery using HADM (Group A) or BC (Group B). Both materials were used as a dura-mater substitutes between the neural tissue and the sutured skin. Correction was performed at gestation day 100 and the fetuses were maintained in utero until term. Sheep were sacrificed on gestation day 140. The fetal spine was submitted to macro and microscopic analysis. At microscopy, adherence of the material to the skin and neural tissue was analyzed. RESULTS: In the initial phase (pilot), experimentally-induced MMC was performed on 11 fetuses and 4 survived (37%). In the second phase (study), 25 fetuses received surgery and 17 survived (68%). In the study group, 6 fetuses did not undergo repair (control group), 11 cases were submitted to corrective surgery (experimental group) and one fetal loss occurred. Of the surviving cases in the experimental group, 4 constituted Group A and 6 in Group B. Macroscopically, skin and underlying tissues where easily displaced from the BC in all cases it was used; in contrast, HADM adhered to these tissues. To compare the adherence, 4 cases from Group A and 4 in Group B were studied. We observed adherence, host cell migration and vessel proliferation into the HADM all sections from Group A and this aspect was not present in any cases in Group B (p < 0.05). In Group B, we also observed that a new fibroblast layer formed around the BC thus protecting the medulla and constituting a "neoduramater". CONCLUSION: The use of BC seems to be more adequate as a dura-mater substitute to cover the damaged neural tissue than HADM. It seems promising for use in the in utero correction of MMC because to does not adhere to neural tissue of superficial and deep layers ("tethered spinal cord"). Thus, BC minimizes the mechanical and chemical intrauterine damage to the spinal medulla.